Moon G. Yoon

Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Comprehensive Multi-Omics Characterization of CYP2R1 as a Diagnostic and Functional Biomarker in Hepatocellular Carcinoma.

Comprehensive Multi-Omics Characterization of CYP2R1 as a Diagnostic and Functional Biomarker in Hepatocellular Carcinoma.

Journal: Medical sciences (Basel, Switzerland)

Published: February 19, 2026

Epigenetic silencing of the liver-specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation.

Epigenetic silencing of the liver-specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation.

Journal: Molecular oncology

Published: February 10, 2026

Systematic transcriptomic analysis of UDP-glucuronosyltransferases reveals UGT2B11 as a diagnostic and metabolic marker in hepatocellular carcinoma.

Systematic transcriptomic analysis of UDP-glucuronosyltransferases reveals UGT2B11 as a diagnostic and metabolic marker in hepatocellular carcinoma.

Journal: BMC cancer

Published: February 05, 2026

DKK1 Suppresses Hippo Signaling via PIP3-OGT-LRP6 O-GlcNAcylation in Hepatocellular Carcinoma.

DKK1 Suppresses Hippo Signaling via PIP3-OGT-LRP6 O-GlcNAcylation in Hepatocellular Carcinoma.

Journal: Cancer communications (London, England)

Published: November 12, 2025

Serum Extracellular Vesicle-Associated GULP1 Is a Key Indicator of Hepatocellular Carcinoma.

Serum Extracellular Vesicle-Associated GULP1 Is a Key Indicator of Hepatocellular Carcinoma.

Journal: Oncology research

Published: July 15, 2025

CTC-537E7.3 as a Liver-Specific Biomarker for Hepatocellular Carcinoma: Diagnostic and Prognostic Implications.

CTC-537E7.3 as a Liver-Specific Biomarker for Hepatocellular Carcinoma: Diagnostic and Prognostic Implications.

Journal: Current issues in molecular biology

Published: June 13, 2025

A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma.

A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma.

Journal: Frontiers in bioscience (Landmark edition)

Published: May 19, 2025

Bacteroides eggerthii ameliorates metabolic dysfunction-associated steatotic liver disease through host-microbe signaling and highlights 2-hydroxyisocaproate as a potential effector.

Bacteroides eggerthii ameliorates metabolic dysfunction-associated steatotic liver disease through host-microbe signaling and highlights 2-hydroxyisocaproate as a potential effector.

Journal: Clinical and molecular hepatology

Published: May 04, 2025

GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma.

GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma.

Journal: Clinical and molecular hepatology

Published: November 19, 2024

Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression.

Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression.

Journal: Scientific reports

Published: October 08, 2024

Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133.

Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133.

Journal: Cell death & disease

Published: March 28, 2024

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma.

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma.

Journal: Cancers

Published: July 07, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026